z-logo
open-access-imgOpen Access
Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant
Author(s) -
Dipnarine Maharaj,
Pedro Vianna,
Gabriel DeCarvalho,
Delaram Pourkalbassi,
Christopher Hickey,
Jacqueline Gouvea
Publication year - 2019
Publication title -
future science oa
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fsoa-2019-0009
Subject(s) - stem cell , immunotherapy , refractory (planetary science) , medicine , lymphoblastic leukemia , oncology , complete remission , precursor cell , cancer research , leukemia , immunology , cell , biology , chemotherapy , cancer , genetics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom